DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $29.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by equities research analysts at Needham & Company LLC from $34.00 to $29.00 in a report released on Friday, Briefing.com reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s target price points to a potential upside of 24.62% from the stock’s current price.

A number of other equities research analysts have also recently weighed in on XRAY. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Finally, Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average price target of $32.67.

DENTSPLY SIRONA Trading Down 4.7 %

XRAY stock traded down $1.14 during midday trading on Friday, hitting $23.27. 1,741,352 shares of the company’s stock were exchanged, compared to its average volume of 2,955,434. DENTSPLY SIRONA has a 1-year low of $22.85 and a 1-year high of $37.60. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The business has a 50-day simple moving average of $25.26 and a two-hundred day simple moving average of $26.58. The stock has a market capitalization of $4.72 billion, a PE ratio of -27.13, a P/E/G ratio of 1.17 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $984.00 million during the quarter, compared to analyst estimates of $993.61 million. During the same period in the previous year, the firm posted $0.51 earnings per share. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.98 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently bought and sold shares of XRAY. UMB Bank n.a. lifted its holdings in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the last quarter. LRI Investments LLC lifted its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $32,000. Allworth Financial LP lifted its holdings in shares of DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $64,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.